In a preclinical study using a murine thymoma model, a comparative study between an anti-pan-CD44 mAb (IM-7) and an anti-murine CD44v10 mAb (K926) was conducted in CD44v10-transfected EL4 thymoma (EL4-v10) [40]. The gene discussed is CD44; the disease is thymoma.